Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D9ZB
|
|||
| Former ID |
DIB005695
|
|||
| Drug Name |
TAK-583
|
|||
| Indication | Diabetic neuropathy [ICD-11: 8C0Z; ICD-10: G63, G63.2] | Phase 2/3 | [1] | |
| Company |
Takeda Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00377598) Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.